Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alx Oncology Holdings (ALXO) Operating Margin (2019 - 2020)

Alx Oncology Holdings' Operating Margin history spans 2 years, with the latest figure at 2046.87% for Q2 2020.

  • On a quarterly basis, Operating Margin fell 172339.0% to 2046.87% in Q2 2020 year-over-year; TTM through Mar 2021 was 3514.42%, a 340016.0% decrease, with the full-year FY2020 number at 808.38%, down 72426.0% from a year prior.
  • Operating Margin hit 2046.87% in Q2 2020 for Alx Oncology Holdings, down from 800.31% in the prior quarter.
  • Over the last five years, Operating Margin for ALXO hit a ceiling of 611.38% in Q4 2019 and a floor of 2046.87% in Q2 2020.